Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023)

Cytek Biosciences (CTKB) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with -$235000.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Income from Non-Controlling Interests fell 71.53% year-over-year to -$235000.0, compared with a TTM value of -$86000.0 through Dec 2023, up 6.52%, and an annual FY2022 reading of -$92000.0, down 453.85% over the prior year.
  • Income from Non-Controlling Interests was -$235000.0 for Q1 2023 at Cytek Biosciences, down from $189000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $315000.0 in Q1 2021 and bottomed at -$315000.0 in Q2 2021.
  • Average Income from Non-Controlling Interests over 3 years is -$37625.0, with a median of -$72000.0 recorded in 2022.
  • Peak annual rise in Income from Non-Controlling Interests hit 626.92% in 2022, while the deepest fall reached 143.49% in 2022.
  • Year by year, Income from Non-Controlling Interests stood at $26000.0 in 2021, then soared by 626.92% to $189000.0 in 2022, then tumbled by 224.34% to -$235000.0 in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for CTKB at -$235000.0 in Q1 2023, $189000.0 in Q4 2022, and -$40000.0 in Q3 2022.